OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9)
Accuracy, sensitivity, specificity, PPV and NPV of 33 predictors using median-score threshold.
Overview
Accuracy, sensitivity, specificity, PPV and NPV of 33 predictors using median-score threshold.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
33 recorded evaluations, 165 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.
Results
Results are available, but no reviewed comparison panel is linked in this release.
All evaluations
33 evaluations · 165 results. Different protocols are not a single leaderboard.
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: CADD (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.64 accuracy fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), B16; Algorithm 'CADD'; column 'Accuracy (±2σ)' |
| Configuration: CADD (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.64 negative-predictive-value fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), F16; Algorithm 'CADD'; column 'NPV (±2σ)' |
| Configuration: CADD (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.64 precision fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), E16; Algorithm 'CADD'; column 'PPV (±2σ)' |
| Configuration: CADD (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.64 recall fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), C16; Algorithm 'CADD'; column 'Sensitivity (±2σ)' |
| Configuration: CADD (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.64 specificity fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), D16; Algorithm 'CADD'; column 'Specificity (±2σ)' |
| Configuration: CanDrA (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.59 accuracy fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), B26; Algorithm 'CanDrA'; column 'Accuracy (±2σ)' |
| Configuration: CanDrA (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.59 negative-predictive-value fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), F26; Algorithm 'CanDrA'; column 'NPV (±2σ)' |
| Configuration: CanDrA (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.59 precision fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), E26; Algorithm 'CanDrA'; column 'PPV (±2σ)' |
| Configuration: CanDrA (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.59 recall fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), C26; Algorithm 'CanDrA'; column 'Sensitivity (±2σ)' |
| Configuration: CanDrA (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.59 specificity fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), D26; Algorithm 'CanDrA'; column 'Specificity (±2σ)' |
| Configuration: CHASM (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.65 accuracy fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), B15; Algorithm 'CHASM'; column 'Accuracy (±2σ)' |
| Configuration: CHASM (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.65 negative-predictive-value fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), F15; Algorithm 'CHASM'; column 'NPV (±2σ)' |
| Configuration: CHASM (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.65 precision fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), E15; Algorithm 'CHASM'; column 'PPV (±2σ)' |
| Configuration: CHASM (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.65 recall fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), C15; Algorithm 'CHASM'; column 'Sensitivity (±2σ)' |
| Configuration: CHASM (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.64 specificity fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), D15; Algorithm 'CHASM'; column 'Specificity (±2σ)' |
| Configuration: CTAT-cancer (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.63 accuracy fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), B18; Algorithm 'CTAT-cancer'; column 'Accuracy (±2σ)' |
| Configuration: CTAT-cancer (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.63 negative-predictive-value fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), F18; Algorithm 'CTAT-cancer'; column 'NPV (±2σ)' |
| Configuration: CTAT-cancer (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.63 precision fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), E18; Algorithm 'CTAT-cancer'; column 'PPV (±2σ)' |
| Configuration: CTAT-cancer (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.63 recall fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), C18; Algorithm 'CTAT-cancer'; column 'Sensitivity (±2σ)' |
| Configuration: CTAT-cancer (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.63 specificity fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceCTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), D18; Algorithm 'CTAT-cancer'; column 'Specificity (±2σ)' |
| Configuration: CTAT-population (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.66 accuracy fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcesomatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), B7; Algorithm 'CTAT-population'; column 'Accuracy (±2σ)' |
| Configuration: CTAT-population (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.66 negative-predictive-value fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcesomatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), F7; Algorithm 'CTAT-population'; column 'NPV (±2σ)' |
| Configuration: CTAT-population (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.66 precision fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcesomatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), E7; Algorithm 'CTAT-population'; column 'PPV (±2σ)' |
| Configuration: CTAT-population (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.66 recall fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcesomatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), C7; Algorithm 'CTAT-population'; column 'Sensitivity (±2σ)' |
| Configuration: CTAT-population (Chen et al. 2020) | Protocol: OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) Dataset: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral) | 0.66 specificity fraction · higher Uncertainty: Not yet extracted: Printed as 'mean (lower-upper)' under the column header '(±2σ)': per Methods, the mean and two standard deviations over 100 random draws. That is not a confidence interval, and the schema's standard_deviation type would need a standard deviation derived from rounded bounds, so no structured uncertainty is recorded. The printed range is kept in printed_source_cell; every range is symmetric about the mean to rounding. Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcesomatic-oncogenicity-20261009-protocol-chen2020-oncokb-median Aggregation: Not reported Comprehensive assessment of computational algorithms in predicting cancer driver mutations; Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Additional file 9 (sheet 'Additional_file_9'), D7; Algorithm 'CTAT-population'; column 'Specificity (±2σ)' |
Source checking is not independent reproduction. Release 2026-10-10-7fcc3e48a123.
Methods and evaluation design
Procedure, tasks and evaluated configurations
Recorded evaluations
Each evaluation records what was tested and under which conditions.
- CADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- CanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- CHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- CTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- CTAT-population on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- DANN on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- DEOGEN2 on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- Eigen on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- Eigen-PC on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- FATHMM-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- FATHMM-disease on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- FATHMM-MKL on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
Baseline coverage
Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.
0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.
No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.
- Author-reported evaluations
- 1
- External evaluations
- 32
Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.
Null control
Proposed control: requires review
Select a task-valid null control after reviewing inputs and metric
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Conventional reference
Proposed control: requires review
Select an upstream conventional reference after reviewing the full protocol
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)
Coverage is derived from release 2026-10-10-7fcc3e48a123. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.
Run instructions
No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.
Strengths, limitations and unresolved questions
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
Release 2026-10-10-7fcc3e48a123 · Record review: source checked
2 source records and release history
- Comprehensive assessment of computational algorithms in predicting cancer driver mutations · Original source · Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML
- Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB) · Original source · 13059_2020_1954_MOESM9_ESM.xlsx
Technical metadata and extraction receipts
Stable ID: somatic-oncogenicity-20261009-protocol-chen2020-oncokb-median
- areas
- dna-genomes
- contexts
- clinical_research
- protocol
- Binary predictions by median-score threshold (each algorithm's median score on the benchmark) compared with the truth labels with reportROC; 400 positives and 400 negatives sampled 100 times; mean and two standard deviations reported.
- version
- Additional file 9
- metric
- accuracy
- limitations
- Binary metrics are means over 100 random draws of 400 positives and 400 negatives; the bracketed range is the mean plus or minus two standard deviations, not a confidence interval.; Predictor scores date from dbNSFP v4.0 and 2019 web servers; current releases (for example AlphaMissense, CHASMplus, BoostDM) are not included.; The threshold is each algorithm's median score on the benchmark draw, which is not available when classifying a new variant; with balanced draws it makes sensitivity, specificity, PPV and NPV nearly equal, so the table ranks tools rather than measuring a usable operating point.; OncoKB annotations are biased towards known, often actionable cancer genes (Discussion).; Some predictors were trained on known cancer mutations, so performance on literature-curated drivers may be inflated.; The OncoKB set has 421 or 497 likely neutral negatives (Methods and Results disagree) and 400 are drawn per repeat, so the draws overlap heavily and the spread understates sampling uncertainty. Results and Methods also disagree on the positive counts, and which positive set fed the binary metrics is not stated.; Two authors (H. Liang, G.B. Mills) co-developed CanDrA (reference 7), and the cell viability labels come from the same group's assays; CanDrA rows are author_reported.
- source locator
- Additional file 9; Methods 'Calculation of five evaluation metrics based on categorical predictions'
Related records
- uses data: OncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)
- assessment: CADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: CanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: CHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: CTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: CTAT-population on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: DANN on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: DEOGEN2 on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: Eigen on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: Eigen-PC on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: FATHMM-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: FATHMM-disease on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: FATHMM-MKL on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: FATHMM-XF on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: GenoCanyon on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: Integrated_fitCons on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: LRT on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: M-CAP on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: MetaLR on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: MetaSVM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: MPC on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: MutationAssessor on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: MutationTaster2 on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: MutPred on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: MVP on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: Polyphen2_HDIV on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: Polyphen2_HVAR on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: PrimateAI on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: PROVEAN on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: REVEL on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: SIFT on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: SIFT4G on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: TransFIC on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessment: VEST4 on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
- assessed by: Assess somatic small-variant oncogenicity